Despite the difficulty in differentiating between NK cells and ILC1s through the use of CD49a/b, it is perhaps still worth noting that peripheral NK cells from prostate cancer patients also express CD49a, along with high levels of the inhibitory receptors PD-1 and TIM-3, and exhibit impaired degranulation (66). Here, ITGA1 is linked to prostate cancer.